References
- Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 432: 15–20
- Ekelund K, Konradsen HB. Invasive group B streptococcal disease in infants: a 19-y nationwide study. Serotype distribution, incidence and recurrent infection. Epidemiol Infect 2004; 132: 1083–90
- Weisner A, Johnson A, Lamegni T, Arnold E, Warner M, Heath P, et al. Characterization of group B streptococci recovered from infants with invasive disease in England and Wales. Clin Infec Dis 2004; 43: 1203–8
- Straková L, Motlová J. Active surveillance of early onset disease due to group B streptococci in newborns. Indian J Med Res 2004; 119(suppl)205–7
- Persson E, Berg S, Trollfors B, Larsson P, Ek E, Backhaus E, et al. Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden, 1998–2001. Clin Microbiol Infect 2004; 10: 791–6
- Davies H, Raj S, Adair C, Robinson J, Mcgeer A. The Alberta GBS study group. Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation. Pediatr Infect Dis J 2001; 20: 879–84
- Farley MM. Group B streptococcal disease in non-pregnant adults. Clin Infect Dis 2001; 43: 556–61
- Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis 2005; 43: 843–7
- Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep 2002; 51: 1–22
- Center for Disease Control Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep 1996;45:1–24.
- Borchardt SM, DeBusscher JH, Tallman PA, Manning SD, Marrs CF, Kurzynski TA, et al. Frequency of antimicrobial resistance among invasive and colonizing group B streptococcal isolates. BMC Infect Dis 2006; 20: 6:57
- De Mouy D, Cavallo JD, Leclercq R, Fabre R. The Aforcopi-Bio Network. Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae. French multicentre study. Antimicrob Agents Chemother 2001; 45: 2400–2
- Fluegge K, Supper S, Siedler A, Berner R. Antibiotic susceptibility in neonatal invasive isolates of Streptococcus agalactiae in a 2-y nationwide surveillance study in Germany. Antimicrob Agents Chemother 2004; 48: 4444–6
- Andrews J, Diekema D, Hunter S, Rhomberg P, Pfaller M, Jones R, et al. Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centres in the Western hemisphere. Am J Obstst Gynecol 2000; 183: 859–62
- Azavedo J, McGavin M, Duncan C, Low D, McGeer A. Prevalence and mechanisms of macrolide resistance in invasive and non-invasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother 2001; 45: 3504–8
- Betriu C, Gomez M, Sanchez A, Cruceyra A, Romero J, Picazo J. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother 1994; 38: 2183–6
- Simoes J, Aroutcheva A, Heimer I, Faro S. Antibiotic resistance patterns of group B streptococcal clinical isolates. Infect Dis Obstet Gynecol 2004; 12: 1–8
- Berg S, Trollfors B, Lagergård T, Zackrisson G, Claesson BA. Serotypes and clinical manifestations of group B streptococcal infections in western Sweden. Clin Microbiol Infect 2000; 6: 9–13
- AB Biodisk, SolnaSweden. www.abbiodisk.com.
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement, 2006; 26: M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
- Manning SD, Foxman B, Pierson CL, Tallman P, Baker CJ, Pearlman MD. Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women. Obstet Gynecol 2003; 118: 1148–50
- von Both U, Ruess M, Mueller U, Fluegge K, Sander A, Berner R. A serotype V clone is predominant among erythromycin-resistant Streptococcus agalactiae isolates in a south-western region of Germany. J Clin Microbiol 2003; 41: 2166–9
- Lin FY, Azimi PH, Weisman LE, Philips JB III, Regan J, Clarg P, et al. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995–1998. Clin Infect Dis 2000; 31: 76–9
- Hnat MD, Gainer J, Bawdon RE, Wender GD. Transplacental passage of vancomycin in the ex vivo human perfusion model. Infect Dis Obstet Gynecol 2004; 12: 57–61
- Swingle HM, Bucciarelli RL, Ayoub EM. Synergy between penicillins and low concentrations of gentamicin in the killing of group B streptococci. J Infect Dis 1985; 152: 515–20